Curing AIDS with CRISPR/CAS: Futuristic vision or contemporary era?

The HI (human immunodeficiency)-virus is one of the major threats to the world's population nowadays. More than 36.7 Million humans are infected with HIV worldwide and approximately 30% of these people do not even know about the deathly virus which invaded their CD4+ Lymphocytes, a sub-population of the withe blood cells, which are a major … Continue reading Curing AIDS with CRISPR/CAS: Futuristic vision or contemporary era?

Advertisements

Xenotransplants: Solution for inreasing shortage of human organ transplants using CRISPRR/CAS9

Transplant shortage is a major problem in our society nowadays. Organ transplantation is the most common cure to treat organ failure but the increasing transplant shortage is the reason why so many patients die because of organ failure nowadays. One highly promising solution for this problem are xenotransplants, this means transplant organs obtained from other … Continue reading Xenotransplants: Solution for inreasing shortage of human organ transplants using CRISPRR/CAS9

CRISPR/CAS9: Next step to designer babies?!

The research group of Ma et al. recently reported in their paper "Correction of a pathogenic gene mutation in human embryos", published in Nature in August 2017, about the application of CRISPR/CAS9 in human embryos to correct a disease-associated mutation. This paper is one of only three published studies using the CRISPR/CAS technology in human embryos. … Continue reading CRISPR/CAS9: Next step to designer babies?!

CRISPR/CAS9 – the discovery of a century

With this post I want to introduce a series of blog post dealing with CRISPR/CAS9 - the latest discovered tool for biologists all over the world. In this article I want to deal with the mechanisms, applications and challenges of CRISPR/CAS9 before presenting three different research projects using the CRISPR technology. The abbreviation CRISPR/CAS9 is … Continue reading CRISPR/CAS9 – the discovery of a century

Patient-derived xenografts as a way to optimal personalized treatment for advanced-state cancer

Cancer is the most common disease in human population. More than 100 different kinds of cancer are characterized today but the number of promising applied treatment strategies  is insufficient to treat any individual type of cancer. Many patients can not be treated with proper medication as only standard therapies are approved for treatment nowadays. Publishing … Continue reading Patient-derived xenografts as a way to optimal personalized treatment for advanced-state cancer

The ‘Half-Earth’ Theory as a global plan for nature conservation?

“Unless humanity learns a great deal more about global biodiversity and moves quickly to protect it, we will soon lose most of the species composing life on Earth.” E.O. Wilson A novel movement of activists and nature lovers are claiming to expand the protection of wildlife and nature by expanding protected areas. But follower and … Continue reading The ‘Half-Earth’ Theory as a global plan for nature conservation?

The alarming present and challenging future of biodiversity on planet earth

" 'Biological diversity' means the variability among living organisms from all sources including, inter alia, terrestrial, marine and other aquatic ecosystems and the ecological complexes of which they are a part; this includes diversity within species, between species and of ecosystems." Convention on Biological Diversity (1992) Climate change and biodiversity loss are considered to be … Continue reading The alarming present and challenging future of biodiversity on planet earth

What is a journal club and do I have to sign up for it?

"Ten simple rules for writing a literature review" by Marco Pautasso et al. "5 Tips for journal club first-timers" by Lucy Bauer The term "journal club" describes a group of persons who meet on regular basis to summarize and discuss recent articles and scientific literature. This method of learning is most commonly used by medical … Continue reading What is a journal club and do I have to sign up for it?